Video Experimental Relacionado
Updated: Jul 11, 2026
10:33
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
Un inhibidor selectivo irreversible dirigido a un dominio de interacción de la proteína PDZ
Naoaki Fujii1, Jose J Haresco, Kathleen A P Novak
1Department of Pharmaceutical Chemistry, University of California at San Francisco, Genentech Hall, Mission Bay, 600 16th Street 2280, San Francisco, California 94143-2280, USA.
Journal of the American Chemical Society
|October 2, 2003
Resumen
Los investigadores desarrollaron un nuevo inhibidor irreversible dirigido a las interacciones proteicas, específicamente el dominio MAGI3 PDZ. Este avance permite estudiar las interacciones proteína-proteína y libera PTEN, regulando al alza la vía PKB.
Área de la Ciencia:
- La bioquímica es la bioquímica.
- Biología Molecular Biología Molecular
- Farmacología Farmacología.
Sus antecedentes:
- Los inhibidores irreversibles de la proteasa son herramientas valiosas para estudiar la actividad y función de las enzimas.
- El diseño de inhibidores irreversibles para las interacciones proteína-proteína, particularmente dirigidos a dominios específicos como la PDZ, ha sido un desafío debido a la falta de principios mecanicistas.
Objetivo del estudio:
- Informar sobre el primer inhibidor irreversible basado en el mecanismo dirigido a una interacción proteica específica, centrándose en el segundo dominio PDZ de MAGI3.
- Demostrar la utilidad del inhibidor en el estudio de la interacción entre PTEN y MAGI3 y sus efectos posteriores en la señalización celular.
Principales métodos:
- Diseño racional de un inhibidor irreversible utilizando evaluación computacional, explotando un residuo de histidina conservado en el dominio MAGI3 PDZ.
- Ensayos in vitro para caracterizar las propiedades del inhibidor y su efecto sobre la interacción PTEN-MAGI3.
- Experimentos basados en células para evaluar el impacto del inhibidor en la liberación de PTEN y la activación de la vía de señalización PKB.
Principales resultados:
- Se diseñó y sintetizó con éxito un nuevo inhibidor irreversible, dirigido al dominio MAGI3 PDZ.
- El compuesto demostró una inhibición irreversible de la interacción PTEN-MAGI3 in vitro.
- En modelos celulares, el inhibidor liberó PTEN de MAGI3 y condujo a la regulación al alza de la vía de señalización PKB.
Conclusiones:
- Este estudio presenta el primer inhibidor irreversible basado en el mecanismo para una interacción proteica, específicamente dirigido al dominio MAGI3 PDZ.
- El inhibidor desarrollado sirve como una poderosa herramienta para diseccionar el papel funcional de la interacción PTEN-MAGI3 en los procesos fisiológicos.
- Los hallazgos abren nuevas vías para estrategias terapéuticas mediante la modulación de las interacciones proteína-proteína y las vías de señalización asociadas.
Videos de Conceptos Relacionados
00:46Feedback Inhibition
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
01:23Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
01:30Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
01:52Eukaryotic Transcription Inhibitors
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...